202 related articles for article (PubMed ID: 999987)
1. Short-term effects of naltrexone in 155 heroin ex-addicts.
Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone: a clinical perspective.
Greenstein RA; Arndt IC; McLellan AT; O'Brien CP; Evans B
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):25-8. PubMed ID: 6469933
[TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
Rawson RA; Tennant FS
NIDA Res Monogr; 1984 Mar; 49():289-95. PubMed ID: 6434974
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
Foster J; Brewer C; Steele T
Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
[TBL] [Abstract][Full Text] [Related]
6. Narcotic antagonists: naltrexone progress report: introduction.
Renault PF
NIDA Res Monogr; 1976 Sep; (9):1-3. PubMed ID: 794713
[No Abstract] [Full Text] [Related]
7. Naltrexone in the treatment of opiate dependence.
Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
[No Abstract] [Full Text] [Related]
8. Factors influencing success in an antagonistic treatment program.
Parwatikar S; Crawford J; Nelkupa JV; De Gracia C
NIDA Res Monogr; 1976 Sep; (9):77-81. PubMed ID: 794725
[No Abstract] [Full Text] [Related]
9. Clinical experience with naltrexone in suburban opioid addicts.
Tennant FS; Rawson RA; Cohen AJ; Mann A
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
[TBL] [Abstract][Full Text] [Related]
10. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
Hulse GK; Morris N; Arnold-Reed D; Tait RJ
Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
[TBL] [Abstract][Full Text] [Related]
11. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics.
Verebey K
NIDA Res Monogr; 1981; 28():147-58. PubMed ID: 6791001
[TBL] [Abstract][Full Text] [Related]
12. Review of naltrexone, a long-acting opiate antagonist.
Crabtree BL
Clin Pharm; 1984; 3(3):273-80. PubMed ID: 6329589
[TBL] [Abstract][Full Text] [Related]
13. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
[TBL] [Abstract][Full Text] [Related]
14. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
15. Methadone and naltrexone in the treatment of heroin dependence.
Greenstein RA; Resnick RB; Resnick E
Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
[TBL] [Abstract][Full Text] [Related]
16. Operant analysis of human heroin self-administration and the effects of naltrexone.
Mello NK; Mendelson JH; Kuehnle JC; Sellers MS
J Pharmacol Exp Ther; 1981 Jan; 216(1):45-54. PubMed ID: 7452507
[TBL] [Abstract][Full Text] [Related]
17. Treatment of heroin-dependent persons with antagonists: current status.
Renault PF
NIDA Res Monogr; 1981; 28():11-22. PubMed ID: 6791000
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone for heroin addiction: encouraging results from Italy.
Schifano F; Marra R
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):144-6. PubMed ID: 2338367
[TBL] [Abstract][Full Text] [Related]
19. Historical perspective on the chemistry and development of naltrexone.
Archer S
NIDA Res Monogr; 1981; 28():3-10. PubMed ID: 6791011
[TBL] [Abstract][Full Text] [Related]
20. A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users.
Hulse GK; Tait RJ
Addict Biol; 2003 Sep; 8(3):337-42. PubMed ID: 13129836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
